Company intelligence / Profile preview

Imperium Master Fund

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Imperium Master Fund is an investment vehicle managed by Imperium Capital, LLC, a New York-based asset management firm. The fund primarily focuses on public and private equity investments within the life sciences, biotechnology, and healthcare sectors. It is known for taking significant positions in clinical-stage biopharmaceutical companies and has historically engaged in activist investing to drive shareholder value. The fund's portfolio often includes companies developing novel therapeutics for metabolic diseases, oncology, and rare disorders.

Industry: Investors

Beyond the preview

Go deeper on Imperium Master Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imperium Master Fund.

Explore the full profile